Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip H Howe

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|March 1, 2005
Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT)Céline Prunier, Philip H Howe
Journal of Cancer Metastasis and Treatment|November 5, 2019
hnRNP E1 at the crossroads of translational regulation of epithelial-mesenchymal transitionSimon Grelet, Philip H Howe
Bio-Protocol|April 13, 2026
ELISA-Based Enzyme Kinetics Assay for Measuring cGAS ActivityCécile Fréreux, Philip H Howe
IUBMB Life|September 30, 2009
The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigmaArindam Chaudhury, Philip H Howe
The Journal of Biological Chemistry|June 5, 2009
Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cellsGary M Wildey, Philip H Howe
Oncoscience|July 24, 2018
Metastasis-associated upregulation of ER-Golgi trafficking kinetics: regulation of cancer progression via the Golgi apparatusBreege V Howley, Philip H Howe
Cytokine|February 4, 2018
TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1Breege V Howley, Philip H Howe
Future Oncology (London, England)|June 17, 2011
Discovery of a metastatic pathway: implications for future cancer treatmentGeorge Hussey, Arindam Chaudhury, Philip H Howe
The EMBO Journal|April 12, 2012
Disabled-2 (Dab2) inhibits Wnt/β-catenin signalling by binding LRP6 and promoting its internalization through clathrinYong Jiang, Xi He, Philip H Howe
RNA (New York, N.Y.)|June 30, 2010
Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory rolesArindam Chaudhury, Praveen Chander, Philip H Howe
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|March 1, 2005
Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT)Céline Prunier, Philip H Howe
Journal of Cancer Metastasis and Treatment|November 5, 2019
hnRNP E1 at the crossroads of translational regulation of epithelial-mesenchymal transitionSimon Grelet, Philip H Howe
Bio-Protocol|April 13, 2026
ELISA-Based Enzyme Kinetics Assay for Measuring cGAS ActivityCécile Fréreux, Philip H Howe
IUBMB Life|September 30, 2009
The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigmaArindam Chaudhury, Philip H Howe
The Journal of Biological Chemistry|June 5, 2009
Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cellsGary M Wildey, Philip H Howe
Oncoscience|July 24, 2018
Metastasis-associated upregulation of ER-Golgi trafficking kinetics: regulation of cancer progression via the Golgi apparatusBreege V Howley, Philip H Howe
Cytokine|February 4, 2018
TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1Breege V Howley, Philip H Howe
Future Oncology (London, England)|June 17, 2011
Discovery of a metastatic pathway: implications for future cancer treatmentGeorge Hussey, Arindam Chaudhury, Philip H Howe
The EMBO Journal|April 12, 2012
Disabled-2 (Dab2) inhibits Wnt/β-catenin signalling by binding LRP6 and promoting its internalization through clathrinYong Jiang, Xi He, Philip H Howe
RNA (New York, N.Y.)|June 30, 2010
Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory rolesArindam Chaudhury, Praveen Chander, Philip H Howe
Pageof 7